Literature DB >> 12507136

Intravascular coagulation: a major secondary insult in nonfatal traumatic brain injury.

Sherman C Stein1, Xiao-Han Chen, Grant P Sinson, Douglas H Smith.   

Abstract

OBJECT: The goal of this study was to determine the frequency with which cerebral intravascular coagulation (IC) complicates traumatic brain injury (TBI). The authors also investigated the incidence of IC in relation to varying mechanisms, time courses, and severities of TBI and in different species.
METHODS: Tissue was sampled from surgical specimens of human cerebral contusions, from rats with lateral fluid-percussion injuries, and from pigs with head rotational acceleration injuries. Immunohistochemical fluorescent staining for antithrombin III was performed to detect cerebral intravascular microthrombi. Abundant IC was found in all specimens, and microthrombi had formed in arterioles and venules of all sizes, ranging from 10 to 600 microm. Although it was more pronounced in focal lesions and more severe injuries, considerable IC was also observed in mild and diffuse injuries. The authors found a strong association between the severity of coagulopathy and the density of IC.
CONCLUSIONS: These results strongly support the contention that IC is a universal response to TBI and an important secondary cerebral insult.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12507136     DOI: 10.3171/jns.2002.97.6.1373

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  34 in total

1.  Blood-brain barrier pathophysiology in traumatic brain injury.

Authors:  Adam Chodobski; Brian J Zink; Joanna Szmydynger-Chodobska
Journal:  Transl Stroke Res       Date:  2011-12       Impact factor: 6.829

2.  Relative Deficiency of Plasma A Disintegrin and Metalloprotease with Thrombospondin Type 1 Repeats 13 Activity and Elevation of Human Neutrophil Peptides in Patients with Traumatic Brain Injury.

Authors:  Monisha A Kumar; Wenjing Cao; Huy P Pham; Dheeraj Raju; Kelsey Nawalinski; Eileen Maloney-Wilensky; James Schuster; X Long Zheng
Journal:  J Neurotrauma       Date:  2018-08-14       Impact factor: 5.269

3.  Predictors of early versus late timing of pulmonary embolus after traumatic injury.

Authors:  Scott C Brakenridge; Seth M Toomay; Jean L Sheng; Larry M Gentilello; Shahid Shafi
Journal:  Am J Surg       Date:  2010-04-10       Impact factor: 2.565

4.  A Porcine Model of Traumatic Brain Injury via Head Rotational Acceleration.

Authors:  D Kacy Cullen; James P Harris; Kevin D Browne; John A Wolf; John E Duda; David F Meaney; Susan S Margulies; Douglas H Smith
Journal:  Methods Mol Biol       Date:  2016

Review 5.  Traumatic brain injury-associated coagulopathy.

Authors:  Jianning Zhang; Rongcai Jiang; Li Liu; Timothy Watkins; Fangyi Zhang; Jing-fei Dong
Journal:  J Neurotrauma       Date:  2012-10-31       Impact factor: 5.269

Review 6.  Coagulopathy in traumatic brain injury.

Authors:  Sherman C Stein; Douglas H Smith
Journal:  Neurocrit Care       Date:  2004       Impact factor: 3.210

Review 7.  Coagulopathy induced by traumatic brain injury: systemic manifestation of a localized injury.

Authors:  Jianning Zhang; Fangyi Zhang; Jing-Fei Dong
Journal:  Blood       Date:  2018-03-05       Impact factor: 22.113

Review 8.  Coagulopathy associated with traumatic brain injury.

Authors:  Monisha A Kumar
Journal:  Curr Neurol Neurosci Rep       Date:  2013-11       Impact factor: 5.081

9.  Blood constituents trigger brain swelling, tissue death, and reduction of glucose metabolism early after acute subdural hematoma in rats.

Authors:  Heidi Baechli; Melika Behzad; Matthias Schreckenberger; Hans-Georg Buchholz; Axel Heimann; Oliver Kempski; Beat Alessandri
Journal:  J Cereb Blood Flow Metab       Date:  2009-11-04       Impact factor: 6.200

10.  Traumatic brain injury associated coagulopathy.

Authors:  Airton Leonardo de Oliveira Manoel; Antonio Capone Neto; Precilla V Veigas; Sandro Rizoli
Journal:  Neurocrit Care       Date:  2015-02       Impact factor: 3.210

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.